Sports nutrition is witnessing rapid growth with a focus on discovering the link between nutrition & performance, ignoring nutrition’s role in EIMD.
High-force eccentric muscle action makes ultrastructural muscular disarrangements in Z-line streaming causing delayed onset of muscle soreness (DOMS), increased circulation of specific intramuscular proteins, swelling, less movement, hampered muscle force capacity & decreased pressure pain threshold immediately & for up to 14 days after the 1st exercise spurt.
The intensity depends upon exercise damage duration & individual’s vulnerability towards a damaging stimulus.
Exercise forms resulting in EIMD comprise resistance training, prolonged running, downhill running & intermittent and high-intensity exercise.
Primary damage – happens due to mechanical work conducted post-contractile & non-contractile disruption initiated by eccentric contraction.
Secondary damage- additional damage is created by an unlimited number of Ca2+ moving inside the cytoplasm. This triggers Ca2+-dependent proteolytic & phospholipase A2 pathways causing protein structure damage. Subsequently, there is Ca2+ overload & permeabilization in the inner mitochondrial membrane and extensive efflux of Ca2+ from the mitochondria, with more intracellular Ca2+ concentration causing apoptosis. There is unmanageable muscle contraction, neutrophil infiltration, proteolysis & proinflammatory cytokine release.
Satellite cells get activated, and muscle regains the potential capacity to organize an increased response to a frequent myofiber homeostasis challenge.
DOMS is the most commonly assessed marker which appears between 8 - 24 h after muscle-damaging exercise, peaks between 24 - 48 h & sinks within 96 h.
2-6 days after initial damage, Cytokinine in plasma and myoglobin in serum appearance peaks.
Skilfully designed nutritional interventions are required to support the recovery process.
Important for muscle protein turnover, adaptive processes, reducing muscle damage markers & enhancing recovery during exercise.
Functional foods –
• Dietary polyphenols-
Quercetin, Catechins & ellagitannins obtained from fruits & vegetables support recovery, provide antioxidant & anti-inflammatory benefits, and weaken arachidonic acid pathways.
• Omega 3 PUFA- n-3 PUFA
Eicosapentaenoic acid (EPA) & docosahexaenoic acid (DHA) from nuts & oily fish give anti-inflammatory advantages.
Vitamin D –
An adequate dose is pivotal for the damaged muscle’s intrinsic repair at the cellular level.
Vitamin C & E-
May scavenge free radicals, and prevent cell damage & inflammation.
Furnish optimistic effects on satellite cell numbers & myonuclear content post exercise & influence skeletal myoblasts myotube formation.
Practical cautious nutritional solutions to modulate EIMD
1. Expand recovery, increase training stimulus, boost adaptive response & reduce performance injuries during EIMD
2. Include a balanced diet enriched with fruits & vegetables
3. Add nutritional supplements under the trainer’s & healthcare professionals’ supervision
EIMD has a complex aetiology comprising difficult contributing factors that sometimes may amplify or resolve muscle damage. Sensible nutritional regimens can establish a delicate periodised steady approach during EIMD.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation